NDC Pharmacologic Class N0000000144 Iron Chelating Activity [MoA]

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Product Type
0078-0467Desferal Deferoxamine MesylateInjection, Powder, Lyophilized, For SolutionIntramuscular; Intravenous; SubcutaneousNovartis Pharmaceuticals CorporationHuman Prescription Drug
0078-0468Exjade DeferasiroxTablet, For SuspensionOralNovartis Pharmaceuticals CorporationHuman Prescription Drug
0078-0469Exjade DeferasiroxTablet, For SuspensionOralNovartis Pharmaceuticals CorporationHuman Prescription Drug
0078-0470Exjade DeferasiroxTablet, For SuspensionOralNovartis Pharmaceuticals CorporationHuman Prescription Drug
0078-0654Jadenu DeferasiroxTablet, Film CoatedOralNovartis Pharmaceuticals CorporationHuman Prescription Drug
0078-0655Jadenu DeferasiroxTablet, Film CoatedOralNovartis Pharmaceuticals CorporationHuman Prescription Drug
0078-0656Jadenu DeferasiroxTablet, Film CoatedOralNovartis Pharmaceuticals CorporationHuman Prescription Drug
0078-0713Jadenu DeferasiroxGranuleOralNovartis Pharmaceuticals CorporationHuman Prescription Drug
0078-0720Jadenu DeferasiroxGranuleOralNovartis Pharmaceuticals CorporationHuman Prescription Drug
0078-0727Jadenu DeferasiroxGranuleOralNovartis Pharmaceuticals CorporationHuman Prescription Drug
0409-2336Deferoxamine Mesylate Deferoxamine MesylateInjection, Powder, Lyophilized, For SolutionIntramuscular; Intravenous; SubcutaneousHospira, Inc.Human Prescription Drug
0409-2337Deferoxamine Mesylate Deferoxamine MesylateInjection, Powder, Lyophilized, For SolutionIntramuscular; Intravenous; SubcutaneousHospira, Inc.Human Prescription Drug
47781-623Deferoxamine Mesylate Deferoxamine MesylateInjection, Powder, Lyophilized, For SolutionIntramuscular; Intravenous; SubcutaneousAlvogen Inc.Human Prescription Drug
47781-624Deferoxamine Mesylate Deferoxamine MesylateInjection, Powder, Lyophilized, For SolutionIntramuscular; Intravenous; SubcutaneousAlvogen Inc.Human Prescription Drug
52609-0006Ferriprox DeferiproneTablet, Film CoatedOralApopharma Usa, Inc.Human Prescription Drug
52609-4502Ferriprox DeferiproneSolutionOralApopharma Usa, Inc.Human Prescription Drug
52609-4504Deferoxamine Mesylate Deferoxamine MesylateInjection, Powder, Lyophilized, For SolutionIntramuscular; IntravenousApopharma Usa, Inc.Human Prescription Drug
52609-4505Deferoxamine Mesylate Deferoxamine MesylateInjection, Powder, Lyophilized, For SolutionIntramuscular; Intravenous; SubcutaneousApopharma Usa, Inc.Human Prescription Drug
63323-597Deferoxamine Deferoxamine MesylateInjection, Powder, Lyophilized, For SolutionIntramuscular; Intravenous; SubcutaneousFresenius Kabi Usa, LlcHuman Prescription Drug
63323-599Deferoxamine Deferoxamine MesylateInjection, Powder, Lyophilized, For SolutionIntramuscular; Intravenous; SubcutaneousFresenius Kabi Usa, LlcHuman Prescription Drug
68083-172Deferoxamine Mesylate Deferoxamine MesylateInjection, Powder, Lyophilized, For SolutionIntramuscular; Intravenous; SubcutaneousGland Pharma LimitedHuman Prescription Drug
68083-173Deferoxamine Mesylate Deferoxamine MesylateInjection, Powder, Lyophilized, For SolutionIntramuscular; IntravenousGland Pharma LimitedHuman Prescription Drug

There are 22 NDC products with the pharmacologic class Iron Chelating Activity [MoA].